In addition, PFKFB4 can control metabolic flux through allosteric regulation of glycolysis; evidence has suggested that restriction of PFKFB4 may confer beneficial effects for cancer treatment as its ectopic expression exhibits a supporting role in the anabolic metabolism in p53-deficient cancer cells [21]. The gene discussed is PFKFB4; the disease is cancer.